Hypertriglyceridemia-induced acute necrotizing pancreatitis: Poor clinical outcomes requiring revisiting management...

Area of Science:

• Gastroenterology and Hepatology
• Internal Medicine
• Critical Care Medicine

Background:

• Hypertriglyceridemia-induced acute pancreatitis (HTG-AP) is a significant cause of acute pancreatitis (AP), ranking third after gallstones and alcohol.
• Current treatment modalities for HTG-AP include supportive care, intravenous insulin, and plasmapheresis, but definitive therapeutic guidelines are lacking.
• Establishing clear treatment protocols is crucial for managing this severe condition and improving patient outcomes.

Observation:

• A rare case of HTG-AP in a 42-year-old male with no prior comorbidities is presented.
• The patient received early interventions including intravenous insulin and plasmapheresis, leading to an initial decrease in triglyceride levels.
• Despite these measures, the patient developed necrotizing pancreatitis and subsequent multi-organ failure.

Findings:

• The case illustrates that even with prompt and aggressive treatment, HTG-AP can progress to severe complications.
• The initial triglyceride reduction did not prevent the development of necrotizing pancreatitis and multi-organ failure.
• This underscores the complex pathophysiology and potential limitations of current therapeutic approaches in severe HTG-AP.

Implications:

• Further research is essential to evaluate the precise role and efficacy of plasmapheresis in managing HTG-AP.
• The findings suggest a need to explore novel or adjunctive therapies for HTG-AP to prevent severe outcomes.
• This case highlights the importance of continued investigation into the optimal management strategies for HTG-AP to improve patient survival and reduce morbidity.